Publications
- Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial2021 | Third Faculty of Medicine
- Phenylketonuria: Inovative therapy with sapropterin2018 | Third Faculty of Medicine
- Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients < 4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial2017 | Central Library of Charles University
- Hyperphenylalaninemia in the Czech Republic: Genotype-phenotype correlations and in silico analysis of novel missense mutations2013 | Third Faculty of Medicine
- Vaříme zdravě a chutně pro fenylketonuriky2022 | Third Faculty of Medicine
- Bedside monitoring of beta-hydroxybutyrate during treatment of diabetic ketoacidosis in children2003 | Third Faculty of Medicine
Loading network view...